Kopfschmerzen und Migräne

Evidenzbasierte Leitlinie zu Diagnose und Therapie
Entwickelt durch das medizinische Wissensnetzwerk evidence.de
der Universität Witten/Herdecke

Referenzen

Hinweis: Nach Möglichkeit wurden Links zu den zitierten Dokumenten respektive den Zusammenfassungen gelegt. Die Links werden erst bei einem Update der Leitlinie erneut überprüft. Sollten Sie Probleme mit „toten Links“ haben, teilen Sie uns dies bitte unter info@evidence.de mit. Oftmals reicht die im Link enthaltene Nummer (PMID), um bei Medline (http://www4.ncbi.nlm.nih.gov/PubMed ) den gewünschten Artikel wieder aufzufinden.

1.AAN, Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurological examinations (summary statement). Neurology, 1994. 44: p. 1353-1354.

2.AAN, Practice parameter: appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 1995. 45(3 Pt 1): p. 585-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7898723&dopt=Abstr act

3.AAN, Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: the electroencephalogram in the evaluation of headache (summary statement). Neurology, 1995. 45: p. 1411-1413.

4.AAN, American Academy of Neurology: Evidence-Based Guidelines for Migraine Headache. 2000. Link: http://www.aan.com/professionals/practice/guidelines.cfm

5.Adelman, J. U., et al., Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology, 2001. 57(8): p. 1377-83. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11673575&dopt=Abs tract
http://www.neurology.org/cgi/content/full/57/8/1377
http://www.neurology.org/cgi/content/abstract/57/8/1377

6.AHCPR, US Department of Health and Human Services. Agency for Health Care Policy and Research. Acute Pain Management: operative or medical procedures and trauma. Rockville (MD): The Agency; Clinical Practice Guideline No.1. AHCPR Publication No.92-0023. 1993: p. 107.

7.AHCPR, 260.US Department of Health and Human Services. Agency for Health Care Policy and Research.Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction. Rockville, The Agency Clinical Practice Guideline No. 11. AHCPR Publication No. 94-0612. 1994.

8.Ahrens, S. P., et al., Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group. Cephalalgia, 1999. 19(5): p. 525-30. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10403069&dopt=Abs tract

9.AKdÄ, Arzneimittelkommission der deutschen Ärzteschaft: Kontraindikation bei Sumatriptan beachten! Dt Ärztebl, 1995. 92: p. A-1546.

10.AKdÄ, Arzneimittelkommission der deutschen Ärzteschaft: Empfehlungen zur Therapie chronischer Kopf- und Gesichtsschmerzen. Oktober 2001. 3. Auflage. Link: http://www.akdae.de/35/10Hefte/89_KopfGesichtschmerz_2001_3Auflage.pdf

11.Akpek, S., et al., Cost-effectiveness of computed tomography in the evaluation of patients with headache. Headache, 1995. 35(4): p. 228-30. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7775181&dopt=Abstr act

12.Allen, C., et al., Rizatriptan wafer--sublingual vs. placebo at the onset of acute migraine. Cephalalgia, 2001. 21(1): p. 77. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11298669&dopt=Abs tract

13.Andersson, P. G., et al., Double-blind study of naproxen vs placebo in the treatment of acute migraine attacks. Cephalalgia, 1989. 9(1): p. 29-32. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2650879&dopt=Abstr act

14.Andrasik, F., Behavioral management of migraine. Biomed Pharmacother, 1996. 50(2): p. 52-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8761709&dopt=Abstr act

15.Arnold, G. and Einhaupl, K. M., [Valproic acid in prophylactic treatment of migraine]. Nervenarzt, 1998. 69(10): p. 913-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9834484&dopt=Abstr act

16.Ashina, M., et al., In vivo evidence of altered skeletal muscle blood flow in chronic tension-type headache. Brain, 2002. 125(Pt 2): p. 320-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11844732&dopt=Abs tract
http://brain.oupjournals.org/cgi/content/full/125/2/320
http://brain.oupjournals.org/cgi/content/abstract/125/2/320

17.AWMF, Medikamentös chronifizierte oder induzierte Kopfschmerzen, AWMF-Leitlinien-Register Nr. 038/005. Leitlinien der Deutschen Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN), AWMF online.

18.Baker, H. L., Jr., Cranial CT in the investigation of headache: cost-effectiveness for brain tumors. J Neuroradiol, 1983. 10(2): p. 112-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6410008&dopt=Abstr act

19.Bank, J., A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis. Headache, 1994. 34(8): p. 476-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7960733&dopt=Abstr act

20.Barnsley, L., Lord, S., and Bogduk, N., Whiplash injury. Pain. 1994. 58: p. 283-307.

21.Basler, H.D., et al., Psychologische Schmerztherapie. 1996, Springer: Heidelberg.

22.Becker, L. A., et al., Use of CT scans for the investigation of headache: a report from ASPN, Part 1. J Fam Pract, 1993. 37(2): p. 129-34. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8336092&dopt=Abstr act

23.Becker, W. J., Use of oral contraceptives in patients with migraine. Neurology, 1999. 53(4(Suppl 1)): p. S19-25. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10487509&dopt=Abs tract

24.Bekkelund, S. I. and Salvesen, R., Drug-associated headache is unrecognized in patients treated at a neurological centre. Acta Neurol Scand, 2002. 105(2): p. 120-3. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11903122&dopt=Abs tract

25.Bendtsen, L., Jensen, R., and Olesen, J., A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry, 1996. 61(3): p. 285-90. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8795600&dopt=Abstr act

26.Bigal, M. E., Bordini, C. A., and Speciali, J. G., Intravenous metamizol (Dipyrone) in acute migraine treatment and in episodic tension-type headache--a placebo-controlled study. Cephalalgia, 2001. 21(2): p. 90-5. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11422089&dopt=Abs tract

27.Blanchard, E. B., Andrasik, F., and Ahles, T. A., Migraine and tension headache. a metaanalytic review. Behav Th, 1980. 11: p. 613-631.

28.Blanchard, E. B., et al., Placebo-controlled evaluation of abbreviated progressive muscle relaxation and of relaxation combined with cognitive therapy in the treatment of tension headache. J. Consult Clin Psychol, 1990. 58: p. 210-215.

29.Bomhof, M., et al., Comparison of rizatriptan 10 mg vs. naratriptan 2,5 mg in migraine. Eur Neurol, 1999. 42: p. 173-179.

30.Boureau, F., et al., A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine. Int J Clin Pract, 2000. 54(5): p. 281-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10954953&dopt=Abs tract

31.Bove, G. and Nilsson, N., Spinal manipulation in the treatment of episodic tension-type headache: a randomized controlled trial. Jama, 1998. 280(18): p. 1576-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9820258&dopt=Abstr act

32.Bremerich, A., Der Gesichtsschmerz aus kieferchirugischer Sicht. Eur J Pain, 1992. 13: p. 64-68.

33.Brennum, J., Brinck, T., and Schriver, L., Sumatriptan has no clinically relevant effect in the treatment of episodic tension-type headache. Eur J Neurol, 1996. 3: p. 23-28.

34.Bruni, O., Galli, F., and Guidetti, V., Sleep hygiene and migraine in children and adolescents. Cephalalgia, 1999. 19 Suppl 25: p. 57-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10668125&dopt=Abs tract

35.Brunner, F. P. and Selwood, N. H., End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. EDTA-ERA Registry Committee. Nephrol Dial Transplant, 1994. 9(10): p. 1371-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7816247&dopt=Abstr act

36.Bundesausschuss-der-Ärzte-und-Krankenkassen, Akupunktur. Zusammenfassender Bericht des Arbeitsausschusses »Ärztliche Behandlung« des Bundesausschusses der Ärzte und Krankenkassen über die Beratungen der Jahre 1999 und 2000 zur Bewertung der Akupunktur gemäß § 135 Abs. 1 SGB V. Köln. 22.01.2001.

37.Bussone, G., et al., Biofeedback-assisted relaxation training for young adolescents with tension-type headache: a controlled study. Cephalalgia, 1998. 18(7): p. 463-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9793698&dopt=Abstr act

38.Buzzi, M. G., Bonamini, M., and Moskowitz, M. A., Neurogenic model of migraine. Cephalalgia, 1995. 15(4): p. 277-80. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7585923&dopt=Abstr act

39.Cabarrocas, X. and Zayas, J. M., on behalf of the Almotriptan Oral Study Group: Efficacy data on oral almotriptan, a novel 5-HT1B/D agonist. Headache, 1998. 38: p. 377-378.

40.Cabarrocas, X. and Zayas, J. M., for and on behalf of the Almotriptan Comparative Study Group: Advantageous tolerability of almotriptan 12.5 mg compared with sumatriptan 1000 mg. Headache, 1999. 39: p. 347.

41.Cady, R. K., et al., Responsiveness of non-IHS migraine and tension-type headache to sumatriptan. Cephalalgia, 1997. 17(5): p. 588-90. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9251874&dopt=Abstr act

42.Cady, R. K., et al., Treatment of mild headache in disabled migraine sufferers: Results of the Spectrum Study. Headache, 2001. 40: p. 792-797.

43.Cala, L. A. and Mastaglia, F. L., Computerized axial tomography findings in a group of patients with migrainous headaches. Proc Aust Assoc Neurol, 1976. 13: p. 35-41. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1029005&dopt=Abstr act

44.Carrera, G. F., et al., Computed tomography of the brain in patients with headache or temporal lobe epilepsy: findings and cost-effectiveness. J Comput Assist Tomogr, 1977. 1(2): p. 200-3. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=97333&dopt=Abstrac t

45.Caselli, R. J., Hunder, G. G., and Whisnant, J. P., Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology, 1988. 38(3): p. 352-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3347337&dopt=Abstr act

46.Celentano, D. D., et al., Medication use and disability among migraineurs: a national probability sample survey. Headache, 1992. 32(5): p. 223-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1628958&dopt=Abstr act

47.Chabriat, H., et al., Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicentre double-blind placebo controlled study. Cephalalgia, 1994. 14: p. 297-300.

48.Cooke, L. J., Rose, M. S., and Becker, W. J., Chinook winds and migraine headache. Neurology, 2000. 54(2): p. 302-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10668687&dopt=Abs tract

49.Couch, J. R. and Hassanein, R. S., Amitriptyline in migraine prophylaxis. Arch Neurol, 1979. 36(11): p. 695-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=508127&dopt=Abstra ct

50.Couch, J. R., Ziegler, D. K., and Hassanein, R., Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects. Neurology, 1976. 26(2): p. 121-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=943066&dopt=Abstra ct

51.Cuetter, A. C. and Aita, J. F., CT scanning in classic migraine. Headache, 1983. 23(4): p. 195. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6885413&dopt=Abstr act

52.Cull, R. E., Investigation of late-onset migraine. Scott Med J, 1995. 40(2): p. 50-2. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7618069&dopt=Abstr act

53.Dahlof, C., Placebo-controlled clinical trials with ergotamine in the acute treatment of migraine. Cephalalgia, 1993. 13(3): p. 166-71. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8358774&dopt=Abstr act

54.Dahlöf, C., et al., Zolmitriptan, a 5-HT1B/1D receptor agonist for the acute oral treatment of migraine: a multicentre, doserange finding study. Eur J Neurol, 1998. 5: p. 535-543.

55.Dahlof, C. G. and Mathew, N., Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern? Cephalalgia, 1998. 18(8): p. 539-45. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9827245&dopt=Abstr act

56.Dahlöf, C., et al., Within-patient consistency of response of rizatriptan for treating migraine. Neurology, 2000. 55: p. 1511-1516.

57.Darling, M., Exercise and migraine. A critical review. J Sports Med Phys Fitness, 1991. 31(2): p. 294-302. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1753739&dopt=Abstr act

58.De Benedittis, G., et al., Magnetic resonance imaging in migraine and tension-type headache. Headache, 1995. 35(5): p. 264-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7775189&dopt=Abstr act

59.de Lissovoy, G. and Lazarus, S. S., The economic cost of migraine. Present state of knowledge. Neurology, 1994. 44(6 Suppl 4): p. S56-62. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8008226&dopt=Abstr act

60.Demaerel, P., et al., The role of cranial computed tomography in the diagnostic work-up of headache. Headache, 1996. 36(6): p. 347-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8707550&dopt=Abstr act

61.Diamond, S. and Freitag, F. G., Cold as an adjunctive therapy for headache. Postgrad Med, 1986. 79(1): p. 305-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3941818&dopt=Abstr act

62.Dichgans, J., et al., [Chronic analgesic-induced headache]. Dtsch Med Wochenschr, 1984. 109(10): p. 369-73. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6141924&dopt=Abstr act

63.Diener, H., Leitlinien zur Therapie der Deutschen Migräne- und Kopfschmerzgesellschaft (Kopfschmerz-NEWS). 2002. 11.Jg Nr.2. Link: www.dmkg.de

64.Diener, H., Therapie der Migräne. Leitlinien der Deutschen Gesellschaft für Neurologie (DGN), 2002. Link: www.dgn.org

65.Diener, H. C., Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group. Cephalalgia, 1999. 19(6): p. 581-8; discussion 542. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10448545&dopt=Abs tract

66.Diener, H. C., et al., Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group. Cephalalgia, 1996. 16(6): p. 441-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8902255&dopt=Abstr act

67.Diener, H. C., et al., Cyclandelate in the prophylaxis of migraine: a placebo-controlled study. Cephalalgia, 2001. 21(1): p. 66-70. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11298666&dopt=Abs tract

68.Diener, H.C., et al., Behandlung der Migräneattacke und Migräneprophylaxe. Dt Ärztebl, 1997. 94: p. A-3092-3102.

69.Diener, H.C., et al., Therapie der Migräneattacke und Migräneprophylaxe. Empfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft (DKMG). Schmerz, 2000. 14: p. 269-283. Nervenheilkunde 2000; 19: 345-353. Akt Neurologie 2000; 27: 273-282. Arzneimitteltherapie 2000. Link: http://www.dmkg.org/ oder http://www.uni-duesseldorf.de/WWW/AWMF/ll/index.html

70.Diener, H.C. and Limmroth, V., The treatment of migraine. Rev Contemp Pharmacother, 1994. 5: p. 271-284.

71.Diener, H.C. and Limmroth, V., Analgesics. Curr Med Res Opinion, 2001, in press.

72.Diener, H.C. and Tfelt-Hansen, P., Headache associated with chronic use of substances, in The Headaches, J. Olesen, P. Tfelt-Hansen, and W. KMA, Editors. 1993, Raven Press: New York. p. 721-727.

73.DMKG, Pressemitteilung der DMKG, Kopfschmerz-News. 4/99.

74.Duarte, J., et al., Headache of recent onset in adults: a prospective population-based study. Acta Neurol Scand, 1996. 94(1): p. 67-70. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8874597&dopt=Abstr act

75.Ducharme, J., Canadian Association of Emergency Physicians Guidelines for the acute management of migraine headache. J Emerg Med, 1999. 17(1): p. 137-44. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9950404&dopt=Abstr act

76.Ducros, A., et al., Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol, 1997. 42(6): p. 885-90. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9403481&dopt=Abstr act

77.Dumas, M. D., Pexman, J. H., and Kreeft, J. H., Computed tomography evaluation of patients with chronic headache. Cmaj, 1994. 151(10): p. 1447-52. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7954139&dopt=Abstr act

78.Edmeads, J., et al., Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci, 1993. 20(2): p. 131-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8334575&dopt=Abstr act

79.Ellis, G. L., et al., The efficacy of metoclopramide in the treatment of migraine headache. Ann Emerg Med, 1993. 22(2): p. 191-5. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8427430&dopt=Abstr act

80.Ernst, E., Homeopathic prophylaxis of headaches and migraine? A systematic review. J Pain Symptom Manage, 1999. 18(5): p. 353-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10584459&dopt=Abs tract

81.Erush, S.C., The pharmacotherapy of migraine in pregnancy. Cephalalgia, 1996. 16: p. 556-564.

82.Essink-Bot, M. L., et al., The impact of migraine on health status. Headache, 1995. 35(4): p. 200-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7775176&dopt=Abstr act

83.Evers, S., et al., Cognitive processing in primary headache: a study on event-related potentials. Neurology, 1997. 48: p. 108-113.

84.Evers, S., et al., Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidemiologic study. Clin Neuropharmacol, 1999. 22(4): p. 201-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10442248&dopt=Abs tract

85.Evers, S., et al., Therapie idiopathischer Kopfschmerzen im Kindesalter. Therapieempfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. Link: www.dmkg.de

86.Ezzo, J., et al., Is acupuncture effective for the treatment of chronic pain? A systematic review. Pain, 2000. 86(3): p. 217-25. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10812251&dopt=Abs tract

87.Ferrari, M. D., et al., Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences. Cephalalgia, 1994. 14(5): p. 330-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7828190&dopt=Abstr act

88.Ferrari, M. D., et al., Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials. Cephalalgia, 2001. 21: p. 129-136.

89.Ferro, J.M., et al., A multivariate study of headache associated with ischemic stroke. Headache, 1995. 35: p. 315-319.

90.Feuerstein, T.J., Antidepressiva zur Therapie chronischer Schmerzen - Metaanalyse. Schmerz, 1997. 3: p. 1-13.

91.Fisher, M. A. and Glass, S., Butorphanol (Stadol): a study in problems of current drug information and control. Neurology, 1997. 48(5): p. 1156-60. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9153436&dopt=Abstr act

92.Fitzpatrick, R. and Hopkins, A., Referrals to neurologists for headaches not due to structural disease. J Neurol Neurosurg Psychiatry, 1981. 44(12): p. 1061-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7334400&dopt=Abstr act

93.Fogelholm, R. and Murros, K., Maprotiline in chronic tension headache: a double-blind cross-over study. Headache, 1985. 25(5): p. 273-5. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3897129&dopt=Abstr act

94.Forsyth, P.A. and Posner, J.B., Headache in patients with brain tumors: a study of 111 patients. Neurology, 1993. 43: p. 1678-1683.

95.Frishberg, B. M., The utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations. Neurology, 1994. 44(7): p. 1191-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8035914&dopt=Abstr act

96.Frishberg, B. M., et al., Evidence-Based Guidelines in the Primary Care Setting: Neuroimaging in Patients with Nonacute Headache; American Academy of Neurology. 2000. Link: http://www.aan.com/professionals/practice/guidelines.cfm

97.Fritsche, G., et al., Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol, 2001. 45(4): p. 229-35. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11385260&dopt=Abs tract
http://www.online.karger.com/library/karger/renderer/dataset.exe?jcode=ENE&action=render&rendertype= fulltext&uid=ENE.ene45229
http://www.karger.com/journals/ene/ene_jh.htm

98.Gaist, D., Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data. Cephalalgia, 1999. 19(8): p. 735-61. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10570730&dopt=Abs tract

99.Gallagher, R. M., et al., A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine. Headache, 2000. 40(2): p. 119-28. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10759911&dopt=Abs tract

100.Gardner, K., et al., A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology, 1997. 49(5): p. 1231-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9371899&dopt=Abstr act

101.Gauthier, J. G. and Carrier, S., Long-term effects of biofeedback on migraine headache: a prospective follow-up study. Headache, 1991. 31(9): p. 605-12. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1774178&dopt=Abstr act

102.Gerber, W., Kopfschmerz und Migäne. 1998, München: Mosaik Verlag.

103.Gerber, W. D., et al., Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time- series analysis. Cephalalgia, 1991. 11(1): p. 37-45. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2036669&dopt=Abstr act

104.Gerber, W. -D., Göbel, H., and Mildenstein, K., Migräne-Patienten-Seminar (MIPAS) in Vorbereitung.

105.Gerber, W. D. and Kropp, P., Migräne als Reizverarbeitungsstörung? Empirische Untersuchung zu continenten negativen Variation bei Migränepatienten. Schmerz, 1993. 7: p. 280-286.

106.Gerber, W. D., et al., Bewegungs- und Sporttherapie bei chronischen Kopfschmerzen., in Verhaltensmedizin: Ergebnisse und Perspektiven interdisziplinärer Forschung, W.D. Gerber, W. Miltner, and K. Mayer, Editors. 1987, edition medizin: Weinheim. p. 55-66.

107.Gerber, W. D., et al., Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study. Funct Neurol, 1995. 10(1): p. 27-35. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7649498&dopt=Abstr act

108.Gervil, M., et al., The relative role of genetic and environmental factors in migraine without aura. Neurology, 1999. 53(5): p. 995-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10496258&dopt=Abs tract

109.Gfeller, J. D., Chibnall, J. T., and Duckro, P. N., Postconcussion symptoms and cognitive functioning in posttraumatic headache patients. Headache, 1994. 34(9): p. 503-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8002321&dopt=Abstr act

110.Gijsman, H., et al., Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK- 462) in the acute treatment of migraine. Cephalalgia, 1997. 17(6): p. 647-51. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9350384&dopt=Abstr act

111.Gnecchi-Ruscone, T., et al., Effects of ergotamine on myocardial blood flow in migraineurs without evidence of atherosclerotic coronary artery disease. Am J Cardiol, 1998. 81(9): p. 1165-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9605061&dopt=Abstr act

112.Goadsby, P. J., A triptan too far? J Neurol Neurosurg Psychiatry, 1998. 64(2): p. 143-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9489518&dopt=Abstr act

113.Goadsby, P. J., Rizatriptan in acute treatment of migraine: update on new comparative data. Cephalalgia, 2000. 20(Suppl 1): p. 10-5. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11078004&dopt=Abs tract

114.Goadsby, P. J., et al., Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Neurology, 2000. 54: p. 156-163.

115.Göbel, H., Die Kopfschmerzen. 1997, Berlin Heidelberg New York: Springer-Verlag.

116.Göbel, H., et al., Therapie des Clusterkoschmerzes. Therapieempfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. Schmerz, 1998. 12: p. 39-52.

117.Göbel, H., et al., Die exterozeptive Suppression der Aktivität des M. temporalis in der Analyse von Schmerzmechanismen. Der Schmerz, 1996. 10: p. 121-128.

118.Gobel, H., et al., [Effectiveness of Oleum menthae piperitae and paracetamol in therapy of headache of the tension type]. Nervenarzt, 1996. 67(8): p. 672-81. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8805113&dopt=Abstr act

119.Gobel, H., et al., Chronic tension-type headache: amitriptyline reduces clinical headache- duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain, 1994. 59(2): p. 241-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7892022&dopt=Abstr act

120.Göbel, H., et al., Efficacy and tolerability of rizatriptan 10 mg in migraine: experience with 70 527 patients episodes. Headache, 2001. 41: p. 264-270.

121.Gobel, H., et al., Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment. Cephalalgia, 1999. 19(7): p. 676-83; discussion 626. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10524662&dopt=Abs tract

122.Gobel, H., Petersen-Braun, M., and Soyka, D., Die Prävalenz von Kopfschmerzen in Deutschland. Der Schmerz, 1993. 7: p. 287-297.

123.Gobel, H., Petersen-Braun, M., and Soyka, D., The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia, 1994. 14(2): p. 97-106. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8062362&dopt=Abstr act

124.Göbel, H., et al., Achzehnmonatige Langzeitanalyse der Wirksamkeit, Sicherheit und Verträglichkeit von Sumatriptan s. c. in der Akuttherapie von Migräneanfällen. Nervenarzt, 1996. 67: p. 206-213.

125.Goldstein, J. and Keywood, C., Frovatriptan for the acute treatment of migraine: a dose-finding study. Headache, 2002. 42(1): p. 41-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12005274&dopt=Abs tract

126.Goldstein, J., et al., Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group. Headache, 1998. 38(10): p. 737-47. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11284462&dopt=Abs tract

127.Gomersall, J. D. and Stuart, A., Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial. J Neurol Neurosurg Psychiatry, 1973. 36(4): p. 684-90. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=4731336&dopt=Abstr act

128.Gray, R.N., et al., Drug Treatments for the Prevention of Migraine Headache. Technical Review 2.3, (Prepared for the Agency for Health Care Policy and Research under Contract No. 290-94-2025. Available from the National Technical Information Service; NTIS Accession No. 127953.). February 1999.

129.Gruffyd-Jones, K., et al., Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a radomize, double-blind, internationale study. 2001. 8: p. 237-245.

130.Haag, G., et al., Prophylaxe und Therapie des medikamenteninduzierten Dauerkopfschmerzes. Therapieempfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. Schmerz, 1999. 13: p. 52-57.

131.Haag, G., et al., Die "Freiburger Migränestudie". Ergebnisseder psychologischen Therapie. Schmerz, 1993. 7: p. 298-303.

132.Haas, D. C., Chronic post-traumatic headaches classified and compared with natural headaches. Cephalalgia, 1996. 16(7): p. 486-93. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8933993&dopt=Abstr act

133.Hagen, K., et al., Blood pressure and risk of headache: a prospective study of 22 685 adults in Norway. J Neurol Neurosurg Psychiatry, 2002. 72(4): p. 463-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11909904&dopt=Abs tract
http://jnnp.bmjjournals.com/cgi/content/full/72/4/463
http://jnnp.bmjjournals.com/cgi/content/abstract/72/4/463

134.Harrison, D.L. and Slack, M.K., Meta-analytic review of the effects of subcutaneous sumatriptan in migraine headache (Cochrane Review), in The Cochrane Library, Issue2. 2000: Oxford: Update Software.

135.Havanka, H., et al., Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group. Clin Ther, 2000. 22(8): p. 970-80. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10972633&dopt=Abs tract

136.Havanka-Kanniainen, H., Treatment of acute migraine attack: ibuprofen and placebo compared. Headache, 1989. 29(8): p. 507-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2676908&dopt=Abstr act

137.Hermann, C., Kim, M., and Blanchard, E. B., Behavioral and prophylactic pharmacological intervention studies of pediatric migraine: an exploratory meta-analysis. Pain, 1995. 60(3): p. 239-55. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7596620&dopt=Abstr act

138.Herrmann, W. M., Kristof, M., and Sastre, M., Preventive treatment of migraine headache with a new isoergolenyl derivative. J Int Med Res, 1978. 6(6): p. 476-82. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=363486&dopt=Abstra ct

139.Hershey, A. D., et al., Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache, 2000. 40(7): p. 539-49. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10940092&dopt=Abs tract

140.Holroyd, K. A., et al., Manegement of chronic tension-typ headache with tricyclic antideressant medication, stress manegement therapy, and their combination. A randomized controlled trial. Jama, 2001. 285: p. 2208-2215.

141.Holroyd, K. A. and Penzien, D. B., Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials. Pain, 1990. 42(1): p. 1-13. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2146583&dopt=Abstr act

142.Holroyd, K. A. and Penzien, D. B., Psychosocial interventions in the management of recurrent headache disorders. 1: Overview and effectiveness. Behav Med, 1994. 20(2): p. 53-63. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7803937&dopt=Abstr act

143.Holroyd, K. A., Penzien, D. B., and Cordingley, G. E., Propranolol in the management of recurrent migraine: a meta-analytic review. Headache, 1991. 31(5): p. 333-40. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1830566&dopt=Abstr act

144.Holroyd, K. A., et al., Flunarizine vs propranolol: a meta-analysis of clinical trials. Headache, 1992. 32: p. 256.

145.Holroyd, K. A., et al., Psychosocial correlates and impact of chronic tension-type headaches. Headache, 2000. 40(1): p. 3-16. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10759896&dopt=Abs tract

146.Honkasalo, M. L., et al., Migraine and concomitant symptoms among 8167 adult twin pairs. Headache, 1995. 35(2): p. 70-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7737864&dopt=Abstr act

147.Housepian, E.M. and Pool, J.L., A systemetic review of intracranial aneurysms from the autopsy file of the Presbyterian Hospital 1914-1956. J Neuropathol Exp Neurol, 1958. 17: p. 409-423.

148.Hungerford, G. D., du Boulay, G. H., and Zilkha, K. J., Computerised axial tomography in patients with severe migraine: a preliminary report. J Neurol Neurosurg Psychiatry, 1976. 39(10): p. 990-4. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1003244&dopt=Abstr act

149.Husein, A. M. and Haq, N., Cerebral arteritis with unusual distribution. Clin Radiol, 1990. 41(5): p. 353-4. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2354606&dopt=Abstr act

150.ICD-10, Auszug aus „Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme in der 10. Revision (ICD-10)“ [ICD-10-SGB-V, Version 2.0]. Link: www.dimdi.de

151.ICSI, Health Care Guideline: Migraine Headache. Institute for Clinical Systems Improvement (ICSI), May 2000. Link: http://www.icsi.org/guide/Migran.pdf

152.Igarashi, H., et al., Magnetic resonance imaging of the brain in patients with migraine. Cephalalgia, 1991. 11(2): p. 69-74. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1860133&dopt=Abstr act

153.IHS, Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia, 1988. 8(Suppl 7): p. 1-96. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3048700&dopt=Abstr act , auch: www.i-h-s.org

154.Jacobson, E., Progressive relaxation. 1938, Chicago: University of Chicago Press.

155.Jensen, R., Brinck, T., and Olesen, J., Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology, 1994. 44(4): p. 647-51. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8164818&dopt=Abstr act

156.Jensen, R., et al., Muscle tenderness and pressure pain thresholds in headache. A population study. Pain, 1993. 52(2): p. 193-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8455967&dopt=Abstr act

157.Johannsson, V., et al., Atenolol in migraine prophylaxis a double-blind cross-over multicentre study. Headache, 1987. 27(7): p. 372-4. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3308768&dopt=Abstr act

158.Jorgensen, H.S., et al., Headache in stroke: the Copenhagen stroke study. Neurologie, 1994. 44: p. 1793-1797.

159.Kahn, C. E., Jr., et al., Computed tomography for nontraumatic headache: current utilization and cost-effectiveness. Can Assoc Radiol J, 1993. 44(3): p. 189-93. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8504331&dopt=Abstr act

160.Kangasniemi, P. and Hedman, C., Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study. Cephalalgia, 1984. 4(2): p. 91-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6428749&dopt=Abstr act

161.Kaniecki, R. G., A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura. Arch Neurol, 1997. 54(9): p. 1141-5. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9311358&dopt=Abstr act

162.Karst, M., et al., Needle acupuncture in tension-type headache: a randomized, placebo- controlled study. Cephalalgia, 2001. 21(6): p. 637-42. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11531895&dopt=Abs tract

163.Karst, M., et al., Pressure pain threshold and needle acupuncture in chronic tension-type headache--a double-blind placebo-controlled study. Pain, 2000. 88(2): p. 199-203. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11050375&dopt=Abs tract

164.Kaube, H., et al., Sumatriptan misuse in daily chronic headache. BMJ, 1994. 308: p. 1573.

165.Keidel, M. , et al., Posttraumatischer Kopfschmerz nach Schädel-Hirn-Trauma und HWS-Distorsion. Therapieempfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. Link: www.dmkg.de

166.Keidel, M. and Diener, H.C., Der posttraumatische Kopfschmerz. Nervenarzt, 1997. 68: p. 769-777.

167.Kellstein, D. E., et al., Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo- controlled, dose-ranging study. Cephalalgia, 2000. 20(4): p. 233-43. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10999673&dopt=Abs tract

168.Klapper, J., Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia, 1997. 17(2): p. 103-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9137847&dopt=Abstr act

169.Klassen, A., et al., Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group. Headache, 1997. 37(10): p. 640-5. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9439085&dopt=Abstr act

170.Klein, K.B., A review of the efficacy of zolmitriptan (311C90) - A new acute treatment for migraine. Frontiers of Headache Research, 1997: p. 263-266.

171.Kloster, R., Nestvold, K., and Vilming, S. T., A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia, 1992. 12(3): p. 169-71; discussion 128. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1623513&dopt=Abstr act

172.Knaus, W. A. and Davis, D. O., Utilization and cost-effectiveness of cranial computed tomography at a university hospital. J Comput Assist Tomogr, 1978. 2(2): p. 209-14. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=100533&dopt=Abstra ct

173.Kramer, M. S., et al., A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group. Neurology, 1998. 51(3): p. 773-81. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9748025&dopt=Abstr act

174.Krobot, K. J., Steinberg, H. W., and Pfaffenrath, V., Migraine prescription density and recommendations. Results of the PCAOM Study. Cephalalgia, 1999. 19(5): p. 511-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10403067&dopt=Abs tract

175.Kroner-Herwig, B., Mohn, U., and Pothmann, R., Comparison of biofeedback and relaxation in the treatment of pediatric headache and the influence of parent involvement on outcome. Appl Psychophysiol Biofeedback, 1998. 23(3): p. 143-57. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10384247&dopt=Abs tract

176.Kropp, P. and Gerber, W.D., Prediction of migraine using a slow cortical potential, the contingent negtive variation. Neurosi Lett, 1998. 4: p. 73-76.

177.Kropp, P., et al., Elektrophysiologische Untersuchungen bei Kopfschmerzen: Die "contingent negative variation" (CNV). Schmerz, 1996. 10: p. 130-134.

178.Krymchantowski, A. V., Naproxen sodium decreases migraine recurrence when adminstered with sumatriptan. Arq Neuropsiquiar, 2000. 58: p. 428-430.

179.Krymchantowski, A. V., Adriano, M., and Fernandes, D., Tolfenamic acid decreases migraine recurrence when used with sumatriptan. Cephalalgia, 1999. 19(3): p. 186-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10234467&dopt=Abs tract

180.Kuhn, M. J. and Shekar, P. C., A comparative study of magnetic resonance imaging and computed tomography in the evaluation of migraine. Comput Med Imaging Graph, 1990. 14(2): p. 149-52. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2334888&dopt=Abstr act

181.Kumral, E., et al., Headache at stroke onset: the Lausanne Stroke Registry. J Neurol Neurosurg Psychiatry, 1995. 58(4): p. 490-2. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7738564&dopt=Abstr act

182.Lamsudin, R. and Sadjimin, T., Comparison of the efficacy between flunarizine and nifedipine in the prophylaxis of migraine. Headache, 1993. 33(6): p. 335-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8349477&dopt=Abstr act

183.Lance, J. W., The controlled application of cold and heat by a new device (Migra-lief apparatus) in the treatment of headache. Headache, 1988. 28(7): p. 458-61. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3243707&dopt=Abstr act

184.Lange, R., Schwartz, J.A., and Hohn, M., Acetylsalicylic acid effervescent 1000 mg (Aspirin) in acute migraine attacks; a multicentre, randomized, double-blind , single-dose, placebo-controlled parallel group study. Cephalalgia, 2000. 20: p. 663-667.

185.Langemark, M., et al., Decreased nociceptive flexion reflex threshold in chronic tension-type headache. Arch Neurol, 1993. 50(10): p. 1061-4. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8215965&dopt=Abstr act

186.Langemark, M., et al., Clomipramine and mianserin in the treatment of chronic tension headache. A double-blind, controlled study. Headache, 1990. 30(3): p. 118-21. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2182566&dopt=Abstr act

187.Langemark, M. and Olesen, J., Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory double-blind trial. Headache, 1994. 34(1): p. 20-4. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8132436&dopt=Abstr act

188.Langman, M.J.S., et al., Risk of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet, 1994. 343: p. 1075-1078. 

189.Larson, E. B., Omenn, G. S., and Lewis, H., Diagnostic evaluation of headache. Impact of computerized tomography and cost-effectiveness. Jama, 1980. 243(4): p. 359-62. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6766193&dopt=Abstr act

190.Leone, M., et al., Cervicogenic headache: a critical review of the current diagnostic criteria. Pain, 1998. 78(1): p. 1-5. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9822206&dopt=Abstr act

191.Limmroth, V., Katsarava, Z., and Diener, H. C., Acetylsalicylic acid in the treatment of headache. Cephalalgia, 1999. 19(6): p. 545-51. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10448540&dopt=Abs tract

192.Limmroth, V., et al., Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Lancet, 1999. 353(9150): p. 378. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9950449&dopt=Abstr act

193.Limmroth, V., May, A., and Diener, H.C., Lysine-acetylsalicylic acid in acute migraine attacks. Eur Neurol, 1999. 41: p. 88-93.

194.Linet, M. S., Celentano, D. D., and Stewart, W. F., Headache characteristics associated with physician consultation: a population-based survey. Am J Prev Med, 1991. 7(1): p. 40-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1867898&dopt=Abstr act

195.Linn, F. H., et al., Prospective study of sentinel headache in aneurysmal subarachnoid haemorrhage. Lancet, 1994. 344(8922): p. 590-3. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7914965&dopt=Abstr act

196.Lipton, R. B., et al., Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population- based study. Arch Intern Med, 2000. 160(22): p. 3486-92. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11112243&dopt=Abs tract

197.Lipton, R. B., et al., 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache, 2000. 40(10): p. 783-91. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11135021&dopt=Abs tract

198.Lipton, R. B., et al., Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis. Arch Intern Med, 1992. 152(6): p. 1273-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1599358&dopt=Abstr act

199.Lipton, R. B., et al., Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials. Arch Neurol, 1998. 55(2): p. 210-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9482363&dopt=Abstr act

200.Lipton, R. B., et al., Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial. Jama, 2000. 284(20): p. 2599-605. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11086366&dopt=Abs tract

201.Lledo, A., et al., Acute headache of recent onset and subarachnoid hemorrhage: a prospective study. Headache, 1994. 34(3): p. 172-4. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8200794&dopt=Abstr act

202.Lutschg, J. and Vassella, F., [The treatment of juvenile migraine using flunarizine or propranolol]. Schweiz Med Wochenschr, 1990. 120(46): p. 1731-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2251492&dopt=Abstr act

203.MaassenVanDenBrink, A., et al., Coronary side-effect potential of current and prospective antimigraine drugs. Circulation, 1998. 98(1): p. 25-30. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9665056&dopt=Abstr act

204.MacGregor, E. A., Wilkinson, M., and Bancroft, K., Domperidone plus paracetamol in the treatment of migraine. Cephalalgia, 1993. 13(2): p. 124-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8495454&dopt=Abstr act

205.Maertens de Noordhout, A., Wang, W., and Schoenen, J., Clinical neurophysiology and neurotransmitters. Cephalalgia, 1995. 15(4): p. 301-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7585928&dopt=Abstr act

206.Main, A., Dowson, A., and Gross, M., Photophobia and phonophobia in migraineurs between attacks. Headache, 1997. 37(8): p. 492-5. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9329231&dopt=Abstr act

207.Marcus, D.A., et al., A double-blind provocative study of chocolate as a trigger of headache. Cephalalgia, 1997. 15: p. 101-103.

208.Martinez-Martin, P., et al., Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double- blind, placebo- and active-controlled, multicentre study. Cephalalgia, 2001. 21(5): p. 604-10. Link: file:///O|/evidence/evidence-volltexte/martinez-martin2001cephalalgia.pdf
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11472387&dopt=Abs tract

209.Masdeu, J. C., et al., Atraumatic isolated headache--when to image. American College of Radiology. ACR Appropriateness Criteria. Radiology, 2000. 215 Suppl: p. 487-93. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11037460&dopt=Abs tract oder http://www.acr.org/cgi-bin/fr?tmpl:appcrit,pdf:0487-494_headache-ac.pdf

210.Mastrosimone, F., Iaccarino, C., and de Caterina, G., Efficacy and tolerance of cyclandelate versus pizotifen in the prophylaxis of migraine. J Med, 1992. 23(1): p. 1-16. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1573338&dopt=Abstr act

211.Mathew, N., Tension Type Headache. Acute Pharmakotherapy, in The Headaches, J. Olesen, P. Tfelt-Hansen, and K.M. Welch, Editors. 1993, Raven Press: New York. p. 531-536.

212.Mathew, N. T., A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine. Headache, 2002. 42(1): p. 32-40. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12005273&dopt=Abs tract

213.Mathew, N. T., et al., Migraine prophylaxis with divalproex. Arch Neurol, 1995. 52(3): p. 281-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7872882&dopt=Abstr act

214.May, A., et al., Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine. Brain, 1998. 121(Pt 7): p. 1231-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9679775&dopt=Abstr act

215.May, Arne, Cluster-Kopfschmerzen. Leitlinien der Deutschen Gesellschaft für Neurologie (DGN), 2002. Link: www.dgn.org

216.Mayer, H., et al., Feverfew - eine Alternative bei Migräne. PZ Pharmazie, 1992. 19: p. 26-32.

217.McGrath, P. J., et al., The efficacy and efficiency of a self-administered treatment for adolescent migraine. Pain, 1992. 49(3): p. 321-4. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1408297&dopt=Abstr act

218.Melchart, D., Linde, K., and Fischer, P., Acupuncture for chronic headache. The Cochrane Library, Issue 3. Oxford: Update Software, 1998.

219.Melchart, D., et al., Acupuncture for recurrent headaches: a systematic review of randomized controlled trials. Cephalalgia, 1999. 19(9): p. 779-86; discussion 765. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10595286&dopt=Abs tract

220.Michel, P., et al., Incremental absenteeism due to headaches in migraine: results from the Mig-Access French national cohort. Cephalalgia, 1999. 19(5): p. 503-10. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10403066&dopt=Abs tract

221.Mitchell, C. S., Osborn, R. E., and Grosskreutz, S. R., Computed tomography in the headache patient: is routine evaluation really necessary? Headache, 1993. 33(2): p. 82-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8458727&dopt=Abstr act

222.Mitsias, P. and Ramadan, N. M., Headache in ischemic cerebrovascular disease. Part I: Clinical features. Cephalalgia, 1992. 12(5): p. 269-74. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1423556&dopt=Abstr act

223.Morland, T. J., Storli, O. V., and Mogstad, T. E., Doxepin in the prophylactic treatment of mixed 'vascular' and tension headache. Headache, 1979. 19(7): p. 382-3. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=511541&dopt=Abstra ct

224.Mulleners, W. M., Whitmarsh, T. E., and Steiner, T. J., Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better. Cephalalgia, 1998. 18(1): p. 52-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9601625&dopt=Abstr act

225.Myllyla, V. V., et al., Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study. Headache, 1998. 38(3): p. 201-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9563211&dopt=Abstr act

226.Nappi, G. and Johnson, F.N., The clinical efficacy of zolmitriptan. Rev Contemp Pharmacother, 2000. 11: p. 99-118.

227.Nattero, G., Biale, L., and Savi, L., Lisuride and pizotifen in the treatment of migraine without aura. Cephalalgia, 1991: p. 218-219.

228.Nestvold, K., Kloster, R., and Sulkava, R., Treatment of acute migraine: Naproxen and placebo compared. Headache, 1985. Q 1(3): p. 211.

229.Nicolodi, M., Differential sensitivity to morphine challenge in migraine sufferers and headache-exempt subjects. Cephalalgia, 1996. 16(5): p. 297-304. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8869763&dopt=Abstr act

230.Nyholt, D. R., et al., Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology, 1998. 50(5): p. 1428-32. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9596000&dopt=Abstr act

231.Olesen, J., Tfelt-Hansen, P., and Welch, K. M. A., The headaches. 1993, New York: Raven Press.

232.Olsson, J. E., et al., Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study. Acta Neurol Scand, 1984. 70(3): p. 160-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6391066&dopt=Abstr act

233.O'Neill, B. P. and Mann, J. D., Aspirin prophylaxis in migraine. Lancet, 1978. 2(8101): p. 1179-81. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=82144&dopt=Abstrac t

234.Ophoff, R. A., et al., Familial hemiplegic migraine: involvement of a calcium neuronal channel. Neurologia, 1997. 12 Suppl 5: p. 31-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9436352&dopt=Abstr act

235.Osborn, R. E., Alder, D. C., and Mitchell, C. S., MR imaging of the brain in patients with migraine headaches. AJNR Am J Neuroradiol, 1991. 12(3): p. 521-4. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2058506&dopt=Abstr act

236.Ostergaard, S., et al., Comparison of first degree relatives and spouses of people with chronic tension headache. Bmj, 1997. 314(7087): p. 1092-3. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9133893&dopt=Abstr act

237.Pascual, J. and Berciano, J., Experience in the diagnosis of headaches that start in elderly people. J Neurol Neurosurg Psychiatry, 1994. 57(10): p. 1255-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7931391&dopt=Abstr act

238.Pascual, J., et al., Tolerability and efficacy of almotriptan in the long-term treatment of migraine. Eur Neurol, 2001. 45(4): p. 206-13. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11385257&dopt=Abs tract
http://www.online.karger.com/library/karger/renderer/dataset.exe?jcode=ENE&action=render&rendertype= fulltext&uid=ENE.ene45206
http://www.karger.com/journals/ene/ene_jh.htm

239.Pascual, J., et al., Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study. Cephalalgia, 2000. 20(6): p. 588-96. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11075844&dopt=Abs tract

240.Pascual, J., et al., Cough, exertional, and sexual headaches: an analysis of 72 benign and symptomatic cases. Neurology, 1996. 46(6): p. 1520-4. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8649540&dopt=Abstr act

241.Pascual, J., et al., Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group. Cephalalgia, 2000. 20(5): p. 455-61. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11037741&dopt=Abs tract

242.Patel, M., et al., A meta-analysis of acupuncture for chronic pain. Int J Epidemiol, 1989. 18(4): p. 900-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2695475&dopt=Abstr act

243.Pearce, J. M., Cervicogenic headache: a personal view. Cephalalgia, 1995. 15(6): p. 463-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8706108&dopt=Abstr act

244.Penzien, D. B., et al., Behavorial Management of migraine: results from five dozen group outcome studies (abstract). 1985. 25: p. 162.

245.Perneger, T. V., Whelton, P. K., and Klag, M. J., Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med, 1994. 331(25): p. 1675-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7969358&dopt=Abstr act

246.Petersen-Braun, M. and Göbel, H., Degree of disability, affliction, less of time and working hours of patients with migraine and tension-type headaches in Germany., in Headache classification and epidemiology, J. Olesen, Editor. 1994: New York. p. 351-354.

247.Petersen-Braun, M. and Göbel, H., Names and classification patients with primary headache illness find for their headaches in Germany., in Headache classifikation and epidemiologie., Olesen, Editor. 1994: New York. p. 503-510.

248.Pfaffenrath, V., Kommentar zu: [Gobel, H., et al., [Effectiveness of Oleum menthae piperitae and paracetamol in therapy of headache of the tension type]. Nervenarzt, 1996. 67(8): p. 672-81.]. Kopfschmerz-News, 1997. Nr. 1.

249.Pfaffenrath, V., Persönliche Mitteilung. 2002.

250.Pfaffenrath, V., et al., Die Behandlung des Kopfschmerzes vom Spannungstyp. Empfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. MMW, 1998. 140: p. 519-525.

251.Pfaffenrath, V. and Gerber, W., Chronische Kopfschmerzen. 1992, Stuttgart: Kohlhammer Verlag.

252.Pfaffenrath, V. and Isler, H., Evaluation of the nosology of chronic tension-type headache. Cephalalgia, 1993. 13 Suppl 12: p. 60-2. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8500150&dopt=Abstr act

253.Pilgrim, A.J., The methods used in clinical trials of sumatriptan in migraine. Headache, 1993. 33: p. 280-293.

254.Pittler, M. H., Vogler, B. K., and Ernst, E., Feverfew for preventing migraine. Cochrane Database Syst Rev, 2000. 3. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10908545&dopt=Abs tract
http://www.update-software.com/abstracts/ab002286.htm

255.Pöllmann, W., Keidel, M., and Pfaffenrath, V., Headache and the cervical spine: a critical review. Cephalalgia, 1997. 17: p. 801-816.

256.Pothmann, R. and Lobisch, M., Akutbehandlung des episodischen kindlichen Spannungskopfschmerzes mit Flupirtin und Paracetamol. Schmerz, 2000. 14: p. 1-4.

257.Pradalier, A., et al., Safety and efficacy of combined lysine acetylsalicylate and metoclopramide: repeat intakes in migraine attacks. Headache, 1999. 39: p. 125-131.

258.Primavera, J. P., 3rd and Kaiser, R. S., Non-pharmacological treatment of headache: is less more? Headache, 1992. 32(8): p. 393-5. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1399561&dopt=Abstr act

259.Prusinski, A., Durko, A., and Niczyporuk-Turek, A., [Feverfew as a prophylactic treatment of migraine]. Neurol Neurochir Pol, 1999. 33(Suppl 5): p. 89-95. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10719691&dopt=Abs tract

260.Pryse-Phillips, W. E., et al., Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society. Cmaj, 1997. 156(9): p. 1273-87. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9145054&dopt=Abstr act oder http://www.cmaj.ca/cgi/reprint/156/9/1273.pdf

261.Pryse-Phillips, W. E., et al., Guidelines for the nonpharmacologic management of migraine in clinical practice. Canadian Headache Society. Cmaj, 1998. 159(1): p. 47-54. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9679487&dopt=Abstr act oder http://www.cmaj.ca/cgi/reprint/159/1/47.pdf

262.Rapoport, A. M., et al., Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group. Neurology, 1997. 49(5): p. 1210-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9371896&dopt=Abstr act

263.Rasmussen, B. K., Epidemiology of headache. Cephalalgia, 1995. 15(1): p. 45-68. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7758098&dopt=Abstr act

264.Rasmussen, B. K., Jensen, R., and Olesen, J., A population-based analysis of the diagnostic criteria of the International Headache Society. Cephalalgia, 1991. 11(3): p. 129-34. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1889068&dopt=Abstr act

265.Rasmussen, B. K., Jensen, R., and Olesen, J., Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health, 1992. 46(4): p. 443-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1431724&dopt=Abstr act

266.Rasmussen, B. K., et al., Epidemiology of headache in a general population--a prevalence study. J Clin Epidemiol, 1991. 44(11): p. 1147-57. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1941010&dopt=Abstr act

267.Reid, G. J. and McGrath, P. J., Psychological treatments for migraine. Biomed Pharmacother, 1996. 50(2): p. 58-63. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8761710&dopt=Abstr act

268.Robbins, L. and Friedman, H., MRI in migraineurs. Headache, 1992. 32(10): p. 507-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1468910&dopt=Abstr act

269.Rodrigues, L.A.G. and Jick, H., Risk of upper gastriontestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet, 1994. 343: p. 769-772.

270.Rosenkranz, S., Deutsch, H.J., and Erdmann, E., "Saint Antony's Fire: Ergotamin-induzierte Gefäßspasmen als Ursache akuter ischämischer Syndrome. Dtsch. Med. Wschr., 1997. 122: p. 450-454.

271.Ross-Lee, L. M., et al., Aspirin pharmacokinetics in migraine. The effect of metoclopramide. Eur J Clin Pharmacol, 1983. 24(6): p. 777-85. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6884416&dopt=Abstr act

272.Russell, D., Nakstad, P., and Sjaastad, O., Cluster headache--pneumoencephalographic and cerebral computerized axial tomography findings. Headache, 1978. 18(5): p. 272-3. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=721460&dopt=Abstra ct

273.Ryan, R. E., Sr., Comparative study of nadolol and propranolol in prophylactic treatment of migraine. Am Heart J, 1984. 108(4 Pt 2): p. 1156-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6148878&dopt=Abstr act

274.Ryan, R. E., Sr. and Ryan, R. E., Jr., Migraine prophylaxis: a new approach. Laryngoscope, 1981. 91(9 Pt 1): p. 1501-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7346693&dopt=Abstr act

275.Salobir, B., et al., Classic risk factors, hypercoagulability and migraine in young women with cerebral lacunar infarctions. Acta Neurol Scand, 2002. 105(3): p. 189-95. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11886363&dopt=Abs tract

276.Salomon, GD., et al., Clinical effiacy and tolerabiltiy of 2,5 mg zolmiptriptan of the acute treatment of migraine. Neurology, 1997. 49: p. 1219-1225.

277.Salomon, GD., Skorbiranda, LA., and Gragg, LA., Quality of life and well-being of headache patients: measurement by the medical outcomes study instrument. 1993. 33: p. 351-358.

278.Salonen, R., Naratriptan. Int J Clin Pract, 1999. 53(7): p. 552-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10692743&dopt=Abs tract

279.Sandler, M., et al., Dietary migraine: recent progress in the red (and white) wine story. Cephalalgia, 1995. 15(2): p. 101-3. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7641242&dopt=Abstr act

280.Sanin, L. C., et al., The International Headache Society (IHS) headache classification as applied to a headache clinic population. Cephalalgia, 1994. 14(6): p. 443-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7697705&dopt=Abstr act

281.Saper, J. R., et al., Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache, 1994. 34(9): p. 497-502. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8002320&dopt=Abstr act

282.Sargent, J. D., et al., Use of CT scans in an out-patient headache population: an evaluation. Headache, 1979. 19(7): p. 388-90. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=511543&dopt=Abstra ct

283.Sargent, J. D. and Solbach, P., Medical evaluation of migraineurs: review of the value of laboratory and radiologic tests. Headache, 1983. 23(2): p. 62-5. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6853154&dopt=Abstr act

284.Schellenberg, R., et al., Zur Langzeitwirkung von Cyclandelat und Propanolol bei Migräne nach Beendigung einer viermonatigen medikamentösen Prophylaxe. Nervenheilkunde, 1997. 16: p. 183-187.

285.Schoenen, J., Clinical neurophysiology studies in headache: a review of data and pathophysiological hints. Funct Neurol, 1992. 7(3): p. 191-204. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1500009&dopt=Abstr act

286.Schoenen, J., Exteroceptive suppression of temporalis muscle activity: methodological and physiological aspects. Cephalalgia, 1993. 13(1): p. 3-10. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8448785&dopt=Abstr act

287.Schoenen, J., Cortical electrophysiology in migraine and possible pathogenetic implications. Clin Neurosci, 1998. 5(1): p. 10-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9523052&dopt=Abstr act

288.Schoenen, J. and Wang, W., Tension-type headache, in Headache, P.J. Goadsby and S.D. Silberstein, Editors. 1997, Butterworth-Heinemann: Boston. p. 177-200.

289.Schoenen, J., et al., Potentation instead of habituation characterizes visual evoked potentials in migraine patients between attacks. Europ J Neurol, 1995. 2: p. 115-122.

290.Schuh-Hofer, S., et al., Treatment of acute cluster headache with 20 mg sumatriptan nasal spray-- an open pilot study. J Neurol, 2002. 249(1): p. 94-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11954875&dopt=Abs tract

291.Schumacher, J. and Brähler, E., Prävalenz von Schmerzen in der deutschen Bevölkerung. Ergebnisse repräsentativer Erhebungen mit dem Gießener Beschwerdefragebogen. Schmerz, 1999. 13: p. 375-384.

292.Schwartz, B. S., et al., Epidemiology of tension-type headache. Jama, 1998. 279(5): p. 381-3. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9459472&dopt=Abstr act

293.Schwarzberg, M. N., Application of metoclopramide specificity in migraine attacks therapy. Headache, 1994. 34(7): p. 439-41. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7928330&dopt=Abstr act

294.Sheftell, F., Rapoport, A. M., and Kudrow, W. L., Efficacy of symptomatic treatment of tension and migraine headaches with the suboccipital ice pillow. Headache, 1989. 29: 327.

295.Shimell, C. J., Fritz, V. U., and Levien, S. L., A comparative trial of flunarizine and propranolol in the prevention of migraine. S Afr Med J, 1990. 77(2): p. 75-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2404346&dopt=Abstr act

296.Siebert, G., Zahnärztliche Funktionsdiagnostik mit und ohne Hilfsmittel. 1989, München: Hanser.

298.Silberstein, S. D., Migraine and pregnancy. Neurol Clin, 1997. 15(1): p. 209-31. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9058407&dopt=Abstr act

299.Silberstein, S. D. and Collins, S. D., Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group. Headache, 1999. 39(9): p. 633-43. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11284461&dopt=Abs tract

300.Silberstein, S. and McCrory, D.C., Opioids, in Drug Treatment of Migraine and other Headaches, H.C. Diener, Editor. 2000, Karger: Basel. p. 222-236.

301.Siniatchkin, M., et al., Contingent negative variation in patients with chronic daily headache. Cephalalgia, 1998. 18(8): p. 565-9; discussion 531. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9827249&dopt=Abstr act

302.Siniatchkin, M., Gerber, W. D., and Vein, A., Clinical efficacy and central mechanisms of cyclandelate in migraine: a double-blind placebo-controlled study. Funct Neurol, 1998. 13(1): p. 47-56. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9584874&dopt=Abstr act

303.Siniatchkin, M., et al., Intensity dependence of auditory evoked cortical potentials in migraine families. Pain, 2000. 85(1-2): p. 247-54. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10692625&dopt=Abs tract

304.Sjaastad, O., Fredriksen, T. A., and Pfaffenrath, V., Cervicogenic headache: diagnostic criteria. The Cervicogenic Headache International Study Group. Headache, 1998. 38(6): p. 442-5. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9664748&dopt=Abstr act

305.Smith, L.A., et al., Eletriptan for acute migraine (Cochrane Review), in The Cochrane Library, Issue 3. 2001, Update Software: Oxford.

306.Somerville, B. W. and Herrmann, W. M., Migraine prophylaxis with Lisuride hydrogen maleate--a double blind study of Lisuride versus placebo. Headache, 1978. 18(2): p. 75-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=348647&dopt=Abstra ct

307.Sorensen, P. S., Hansen, K., and Olesen, J., A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine. Cephalalgia, 1986. 6(1): p. 7-14. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3516409&dopt=Abstr act

308.Sorensen, P. S., et al., Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability. Headache, 1991. 31(10): p. 650-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1769820&dopt=Abstr act

309.Sorge, F., et al., Amitriptyline as a prophylactic for migraine in children. Acta Neurol (Napoli), 1982. 4(5): p. 362-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7158453&dopt=Abstr act

310.Sotaniemi, K. A., et al., Clinical and CT correlates in the diagnosis of intracranial tumours. J Neurol Neurosurg Psychiatry, 1991. 54(7): p. 645-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1895130&dopt=Abstr act

311.Stark, R., Dahlöf, C., and Haughie, S., Efficacy, safety and tolerability of oral eleptripan an the acute treatment of migraine: resluts of a phase III, multicentre, placebo-controlled study across the attacks. Cephalalgia, 2002. 22: p. 23-32.

312.Stebhens, W.E., Etiology and pathogenesis of intracranial berry aneurysms, in Intracranial Aneurysms, J.L. Fox, Editor. 1983, Springer-Verlag: New York. p. 358-395.

313.Steiner, T. J., et al., If migraine prophylaxis does not work, think about compliance. Cephalalgia, 1994. 14(6): p. 463-4. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7697710&dopt=Abstr act

314.Steiner, T. J., et al., Metoprolol in the prophylaxis of migraine: parallel-groups comparison with placebo and dose-ranging follow-up. Headache, 1988. 28(1): p. 15-23. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3277926&dopt=Abstr act

315.Steiner, T. J. and Lange, R., Ketoprofen (25 mg) in the symptomatic treatment of episodic tension- type headache: double-blind placebo-controlled comparison with acetaminophen (1000 mg). Cephalalgia, 1998. 18(1): p. 38-43. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9601623&dopt=Abstr act

316.Stellar, S., et al., Migraine prevention with timolol. A double-blind crossover study. Jama, 1984. 252(18): p. 2576-80. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6387197&dopt=Abstr act

317.Stensrud, P. and Sjaastad, O., Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine. Headache, 1980. 20(4): p. 204-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6993420&dopt=Abstr act

318.Stewart, W. F., Celentano, D. D., and Linet, M. S., Disability, physician consultation, and use of prescription medications in a population-based study of headache. Biomed Pharmacother, 1989. 43(10): p. 711-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2640911&dopt=Abstr act

319.Stewart, W. F., et al., Menstrual cycle and headache in a population sample of migraineurs. Neurology, 2000. 55(10): p. 1517-23. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11094107&dopt=Abs tract
http://www.neurology.org/cgi/content/full/55/10/1517
http://www.neurology.org/cgi/content/abstract/55/10/1517

320.Stewart, W. F., et al., Familial risk of migraine: a population-based study. Ann Neurol, 1997. 41(2): p. 166-72. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9029065&dopt=Abstr act

321.Straube, A., Episodischer und chronischer Spannungskopfschmerz. Leitlinien der Deutschen Gesellschaft für Neurologie (DGN), 2002. Link: www.dgn.org

322.Study-Group, The Multinational Oral Sumatripan Cafergot Comperative Study Group. A randomized double-blind comparison of Sumatriptan and Cafergot in the acute tratement or migraine. Eur Neurol, 1991. 31: p. 314-322.

323.Study-Group, A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. Eur Neurol, 1991. 31(5): p. 314-22. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1653139&dopt=Abstr act

324.Study-Group, The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A study to compare oral sumatrpitan with oral aspirin plus oral metoclopramide in  the acute tratement of migraine. Eur Neurol, 1992. 32: p. 177-184. 

325.Study-Group, The long term tolerability and efficacy of oral Zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. Headache, 1998. 38: p. 173-183.

326.Study-Group, Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac- K/Sumatriptan Migraine Study Group. Cephalalgia, 1999. 19(4): p.232-40. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10376168&dopt=Abs tract

327.Sze, G., et al., Comparison of single- and triple-dose contrast material in the MR screening of brain metastases. AJNR Am J Neuroradiol, 1998. 19(5): p. 821-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9613494&dopt=Abstr act

328.Taneri, Z. and Petersen-Braun, M., Therapie des akuten Migräneanfalls mit intravenös applizierter Acetylsalicylsäure - eine placebo-kontrollierte Doppelblindstudie. Schmerz, 1995. 9: p. 124-129.

329.Tansey, M. J., Pilgrim, A. J., and Martin, P. M., Long-term experience with sumatriptan in the treatment of migraine. Eur Neurol, 1993. 33(4): p. 310-5. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8394239&dopt=Abstr act

330.Taubert, K., [Principles for the use of physical therapy in primary headache]. Z Arztl Fortbild (Jena), 1991. 85(1-2): p. 19-22. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2028647&dopt=Abstr act

331.Taubert, K., [Transcutaneous electric nerve stimulation (TENS) in headache and facial pain]. Z Arztl Fortbild (Jena), 1991. 85(1-2): p. 31-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2028649&dopt=Abstr act

332.Teall, J., et al., Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group. Headache, 1998. 38(4): p. 281-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9595867&dopt=Abstr act

333.ter Riet, G., Kleijnen, J., and Knipschild, P., Acupuncture and chronic pain: a criteria-based meta-analysis. J Clin Epidemiol, 1990. 43(11): p. 1191-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2147032&dopt=Abstr act

334.Terwindt, G. M., et al., The impact of migraine on quality of life in the general population: the GEM study. Neurology, 2000. 55(5): p. 624-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10980723&dopt=Abs tract

335.Tfelt-Hansen, P., Efficacy and adverse effects of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on numbers needed to treat. Cephalalgia, 1998. 18(8): p. 532-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9827244&dopt=Abstr act

336.Tfelt-Hansen, P. and Goadsby, P. J., Naratriptan is effective and well tolerated in the acute treatment of migraine. Neurology, 1999. 52(6): p. 1300-1. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10214771&dopt=Abs tract

337.Tfelt-Hansen, P., et al., The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet, 1995. 346(8980): p. 923-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7564725&dopt=Abstr act

338.Tfelt-Hansen, P. and Olesen, J., Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double blind study. Cephalalgia, 1984. 4: p. 107-111.

339.Tfelt-Hansen, P. and Ryan, R. E., Jr., Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials. Neurology, 2000. 55(9(Suppl 2)): p. S19-24. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11089515&dopt=Abs tract

340.Tfelt-Hansen, P., et al., Ergotamine in the acute treatment of migraine: a review and European consensus. Brain, 2000. 123(Pt 1): p. 9-18. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10611116&dopt=Abs tract
http://brain.oupjournals.org/cgi/content/full/123/1/9
http://brain.oupjournals.org/cgi/content/abstract/123/1/9

341.Tfelt-Hansen, P., et al., Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand, 1984. 69(1): p. 1-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6367336&dopt=Abstr act

342.Tfelt-Hansen, P., et al., Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group. Headache, 1998. 38(10): p. 748-55. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11284463&dopt=Abs tract

343.Touchon, J., et al., A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine. Neurology, 1996. 47(2): p. 361-5. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8757005&dopt=Abstr act

344.Treves, T. A., Streiffler, M., and Korczyn, A. D., Naproxen sodium versus ergotamine tartrate in the treatment of acute migraine attacks. Headache, 1992. 32(6): p. 280-2. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1399547&dopt=Abstr act

345.Turner, L. C., et al., Migraine trigger factors in non-clinical Mexican-American population in San Diego county: implications for etiology. Cephalalgia, 1995. 15(6): p. 523-30. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10357602&dopt=Abs tract

346.Ueberall, M. A. and Wenzel, D., Intranasal sumatriptan for the acute treatment of migraine in children. Neurology, 1999. 52(7): p. 1507-10. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10227648&dopt=Abs tract

347.Ulrich, V., et al., Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol, 1999. 45(2): p. 242-6. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9989627&dopt=Abstr act

348.van de Ven, L. L., Franke, C. L., and Koehler, P. J., Prophylactic treatment of migraine with bisoprolol: a placebo- controlled study. Cephalalgia, 1997. 17(5): p. 596-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9251876&dopt=Abstr act

349.van der Wee, N., et al., Detection of subarachnoid haemorrhage on early CT: is lumbar puncture still needed after a negative scan? J Neurol Neurosurg Psychiatry, 1995. 58(3): p. 357-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7897421&dopt=Abstr act

350.van Suijlekom, J. A., et al., Interobserver reliability of diagnostic criteria for cervicogenic headache. Cephalalgia, 1999. 19(9): p. 817-23. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10595292&dopt=Abs tract

351.Vestergaard, K., et al., Headache in stroke. Stroke, 1993. 24(11): p. 1621-4. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8236332&dopt=Abstr act

352.Visser, W. H., et al., Sumatriptan in clinical practice: a 2-year review of 453 migraine patients. Neurology, 1996. 47(1): p. 46-51. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8710123&dopt=Abstr act

353.Visser, W. H., et al., Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients. Cephalalgia, 1996. 16(4): p. 264-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8792039&dopt=Abstr act

354.Visser, W. H., et al., Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group. Arch Neurol, 1996. 53(11): p. 1132-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8912486&dopt=Abstr act

355.Vogler, B. K., Pittler, M. H., and Ernst, E., Feverfew as a preventive treatment for migraine: a systematic review. Cephalalgia, 1998. 18(10): p. 704-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9950629&dopt=Abstr act

356.Volans, G. N., The effect of metoclopramide on the absorption of effervescent aspirin in migraine. Br J Clin Pharmacol, 1975. 2(1): p. 57-63. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=791318&dopt=Abstra ct

357.Walach, H., et al., Classical homeopathic treatment of chronic headaches. Cephalalgia, 1997. 17(2): p. 119-26; discussion 101. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9137850&dopt=Abstr act

358.Wang, W., et al., Specifity and sensitivity of temporalis ES 2 measurements in the diagnosis of chronic primary headaches. Headache, 1995. 35: p. 85-88.

359.Wang, W. and Schoenen, J., Reduction of temporalis exteroceptive suppression by peripheral electrical stimulation in migraine and tension-type headache. Pain, 1994. 59: p. 327-334.

360.Weiller, C., et al., Brain stem activation in spontaneous human migraine attacks. Nat Med, 1995. 1(7): p. 658-60. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7585147&dopt=Abstr act

361.Weingarten, S., et al., The effectiveness of cerebral imaging in the diagnosis of chronic headache. Arch Intern Med, 1992. 152(12): p. 2457-62. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1456857&dopt=Abstr act

362.Weinschütz, T., Akupunktur bei Kopfschmerzen. Methodische Grundlagen und Ergebnisse klinischer Untersuchungen. Schmerz, 1996. 10: p. 149-155.

363.Wekerle, G., Diagnostik und Therapie des cervikogenen Kopfschmerzes. Forschungsergebnisse der DMKG. Link: www.dmkg.de

364.White, A. R., et al., Acupuncture for episodic tension-type headache: a multicentre randomized controlled trial. Cephalalgia, 2000. 20(7): p. 632-7. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11128820&dopt=Abs tract

365.Whitmarsh, T. E., Coleston-Shields, D. M., and Steiner, T. J., Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine. Cephalalgia, 1997. 17(5): p. 600-4. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9251877&dopt=Abstr act

366.Wilkinson, I. M. and Russell, R. W., Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement. Arch Neurol, 1972. 27(5): p. 378-91. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=5078894&dopt=Abstr act

367.Wilkinson, M., et al., Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience. Cephalalgia, 1995. 15(5): p. 337-57. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8536293&dopt=Abstr act

368.Winner, P., et al., A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol, 1996. 53(2): p. 180-4. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8639069&dopt=Abstr act

369.Winther, K., Hedman, C., and Flodgaard, H., Platelet P1, P4-Di (adenosine-51) tetraphosphate (AP4A) in migraine patients before and during beta-adrenoceptor blockade. Eur J Clin Invest, 1990. 20(3): p. 336-8. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2164477&dopt=Abstr act

370.Worz, R., et al., [Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol]. Fortschr Med, 1992. 110(14): p. 268-72. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1351025&dopt=Abstr act

371.Yokoi, K., et al., Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI. Chest, 1999. 115(3): p. 714-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10084481&dopt=Abs tract

372.Zagami, A.S., Chronic tension-type headache - rational frug treatment options. CNS Drugs, 1995. 4: p. 90-98.

373.Zentralinstitut-für-die-kassenärztliche-Versorgung-in-der-Bundesrepublik-Deutschland, Die EVaS-Studie, in Wissenschaftliche Reihe Bd. 39.1. 1989, Deutscher Ärzte-Verlag: Köln.

374.Ziegler, D. K., et al., Migraine in twins raised together and apart. Headache, 1998. 38: p. 417-422.

375.Ziegler, D. K., et al., Migraine prophylaxis. A comparison of propranolol and amitriptyline. Arch Neurol, 1987. 44(5): p. 486-9. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3579659&dopt=Abstr act

376.Ziegler, D. K., et al., Propranolol and amitriptyline in prophylaxis of migraine. Pharmacokinetic and therapeutic effects. Arch Neurol, 1993. 50(8): p. 825-30. Link: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8352668&dopt=Abstr act
 

[Start Leitlinien] [» Asthma] [» Kopfschmerzen] [Algorithmus] [Diagnose Text] [Therapie Text] [Hintergründe] [Referenzen] [Patientenleitlinie] [Impressum] [» Hypertonie] [» Otitis media] [» Gallensteine] [» Herzinsuffizienz] [» Demenz] [» Harnwegsinfekt] [» KR-Karzinom] [» Dekubitus] [Ihre Meinung?] [Interne Infos]